COLUMN GROUP-NEURO II, LP
Profile
Company Names
COLUMN GROUP-NEURO II, LP
Addresses
1 LETTERMAN DRIVE, BUILDING D, SUITE DM-900, SAN FRANCISCO, CA 94129
Phone Numbers
415-865-2050
Entity Type:
LIMITED PARTNERSHIP
Industry:
VENTURE CAPITAL FUND
Year Incorporated:
2024
State Incorporated:
DELAWARE
Total Amount Raised:
$100,000,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2024-02-09
$100,000,000.00
$100,000,000.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
TIM
KUTZKEY
EXECUTIVE OFFICER
CARMOT THERAPEUTICS INC.
| CYTERIX PHARMACEUTICALS INC.
| PELOTON THERAPEUTICS, INC.
| NEURONA THERAPEUTICS INC
| KALLYOPE, INC.
| COLUMN GROUP III-A, LP
| COLUMN GROUP III, LP
| SURROZEN, INC.
| NEURONA THERAPEUTICS, INC
| COLUMN GROUP V, LP
| COLUMN GROUP OPPORTUNITY III, LP
| COLUMN GROUP SPV I, LP
| COLUMN GROUP-NEURO II, LP
| SITE TX, INC.
| NILO THERAPEUTICS, INC.
| NGM BIO HOLDINGS, INC.
PETER
SVENNILSON
EXECUTIVE OFFICER
FARALLON BIOSCIENCES, INC
| NGM BIOPHARMACEUTICALS INC
| COLUMN GROUP II, LP
| ARAGON PHARMACEUTICALS, INC.
| PTC THERAPEUTICS, INC.
| IMMUNE DESIGN CORP.
| COLUMN GROUP II, LP
| COLUMN GROUP III-A, LP
| COLUMN GROUP III, LP
| CONSTELLATION PHARMACEUTICALS INC
| CIRCLE PHARMA, INC.
| CARMOT THERAPEUTICS INC.
| COLUMN GROUP-NEURO, LP
| COLUMN GROUP V, LP
| COLUMN GROUP OPPORTUNITY III, LP
| COLUMN GROUP SPV I, LP
| COLUMN GROUP-NEURO II, LP
| NGM BIO HOLDINGS, INC.
| NEURONA THERAPEUTICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
